MarketScreener Homepage > Equities > Euronext Paris > Innate Pharma IPH FR0010331421

Report

Real-time Euronext Paris - 01/27 11:35:08 am
3.602	EUR		+0.56%

01/05

SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday

01/05

ETF PREVIEW : ETFs, Futures Log Gains Ahead of Georgia Senate Election Runoff Results; ISM Manufacturing Data On Tap

01/05

SANOFI : Innate Pharma Shares Rise as Sanofi Selects its Anti-Tumor Drug Candidate for Development

News

Most relevant

Official Publications

Sector news

Most relevant news about INNATE PHARMA

01/05	SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday	MT
01/05	ETF PREVIEW : ETFs, Futures Log Gains Ahead of Georgia Senate Election Runoff Re..	MT
01/05	SANOFI : Innate Pharma Shares Rise as Sanofi Selects its Anti-Tumor Drug Candida..	MT
01/05	Sanofi Selects Innate's First NK Cell Engager as Anti-Tumor Drug Candidate fo..	MT
01/05	Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..	GL
01/05	INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..	GL
01/04	Innate Pharma to Participate in Upcoming Investor Conferences	GL
01/04	INNATE PHARMA : to participate in upcoming investor conferences	GL
2020	INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..	MT
2020	INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..	MT
2020	INNATE PHARMA : to return US and EU Lumoxiti commercialization rights to AstraZe..	AQ
2020	MIDDAY REPORT : Wall Street Weaker Midday On Stimulus Woes	MT
2020	SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Friday	MT
2020	INNATE PHARMA S A : to Give Up License to AstraZeneca's Leukemia Drug Due to Low..	MT
2020	Innate Pharma To Return Immunotoxin's Commercialization Rights In US, EU To A..	MT
2020	Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZ..	GL
2020	INNATE PHARMA : Innate Pharma to return US and EU Lumoxiti commercialization ri..	GL
2020	Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combinat..	GL
2020	INNATE PHARMA : to Present Additional Efficacy Data for Monalizumab in Combinati..	AQ
2020	INNATE PHARMA : Innate Pharma to present additional efficacy data for monalizum..	GL
2020	INNATE PHARMA : 2021 financial calendar	GL
2020	Innate Pharma 2021 Financial Calendar	GL
2020	Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target	MT
2020	INNATE PHARMA : reports third quarter 2020 financial results and business update	AQ
2020	Innate Pharma Secures EU's PRIME Designation for Lacutamab to Treat Sézary Sy..	MT
2020	INNATE PHARMA : Revenue for Q3	PU
2020	INNATE PHARMA : reports third quarter 2020 financial results and business update	PU
2020	INNATE PHARMA : Reports Third Quarter 2020 Financial Results and Business Update	AQ
2020	INNATE PHARMA : reports third quarter 2020 financial results and business update	AQ
2020	Innate Pharma Reports Third Quarter 2020 Financial Results and Business Updat..	GL
2020	INNATE PHARMA : reports third quarter 2020 financial results and business update	GL
2020	INNATE PHARMA : receives PRIME designation from the European Medicines Agency fo..	AQ
2020	INNATE PHARMA : to participate in upcoming investor conferences	AQ
2020	SECTOR UPDATE : Health Care Stocks Gain Pre-Bell Friday	MT
2020	Innate Pharma Secures European Regulator's PRIME Designation For Lacutamab	MT
2020	INNATE PHARMA : Receives Prime Designation From the European Medicines Agency fo..	AQ
2020	INNATE PHARMA : Receives prime designation from the european medicines agency fo..	GL
2020	INNATE PHARMA : Receives prime designation from the european medicines agency fo..	AQ
2020	Innate Pharma Receives Prime Designation From the European Medicines Agency f..	GL
2020	INNATE PHARMA : to Participate in upcoming investor conferences	AQ
2020	INNATE PHARMA : to participate in upcoming investor conferences	AQ
2020	INNATE PHARMA : to participate in upcoming investor conferences	GL
2020	Innate Pharma to Participate in upcoming investor conferences	GL
2020	INNATE PHARMA LAUNCHES HOPECONNECTLE : A New Online Resource for Hairy Cell Leuk..	AQ
2020	INNATE PHARMA LAUNCHES HOPECONNECTLE : A New Online Resource for Hairy Cell Leuk..	GL
2020	INNATE PHARMA : SA - First patient dosed in monalizumab Phase 3 clinical trial t..	AQ
2020	INNATE PHARMA : Gets $50 Million Milestone Payment From AstraZeneca	DJ
2020	INNATE PHARMA : First patient dosed in monalizumab Phase 3 clinical trial trigge..	AQ
2020	ASTRAZENECA : First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers..	AQ
2020	INNATE PHARMA : First patient dosed in monalizumab Phase 3 clinical trial trigge..	GL
2020	First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payme..	GL
2020	INNATE PHARMA : Interim financial report	PU
2020	INNATE PHARMA : reports first half 2020 financial results and business update	AQ
2020	INNATE PHARMA : Reports First Half 2020 Financial Results and Business Update	AQ
2020	INNATE PHARMA : reports first half 2020 financial results and business update	GL
2020	Innate Pharma Reports First Half 2020 Financial Results and Business Update	GL
2020	Upcoming Investor Conferences	GL
2020	INNATE PHARMA : half-yearly earnings release
2020	INNATE PHARMA : obtains EUR6.8M in public funding for its COVID-19 research and ..	AQ
2020	Innate Pharma Obtains €6.8M in Public Funding for Its COVID-19 Research And D..	GL
2020	Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study F..	GL
2020	INNATE PHARMA : announces the appointment of Joyson Karakunnel, MD, MSC, FACP as..	GL
2020	INNATE PHARMA : U.S. Food and Drug Administration lifts partial clinical hold on..	GL
2020	U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TE..	GL
2020	Outcome Of Annual General Meeting Of May 19, 2020	GL
2020	INNATE PHARMA : Written questions to the Annual General Meeting	PU
2020	INNATE PHARMA : to Present New Efficacy Data For Monalizumab in Combination With..	GL
2020	Innate Pharma to Present New Efficacy Data for Monalizumab in Combination Wit..	GL
2020	INNATE PHARMA : Revenue for Q1	PU
2020	INNATE PHARMA : First Quarter 2020 Report	GL
2020	INNATE PHARMA : AGM convening Notice BALO	PU
2020	INNATE PHARMA : Financial resolutions tables	PU
2020	INNATE PHARMA : Text of resolutions to the 2020 AGM	PU
2020	INNATE PHARMA : Auditor's report PCAOB	PU
2020	INNATE PHARMA : Convening brochure to the 2020 AGM	PU

1 2 3 4 5 6 7 Next

Official Publications

01/11	Corporate Officers and Executives' transac..
01/07	Corporate Officers and Executives' transac..
01/07	Corporate Officers and Executives' transac..
01/07	Corporate Officers and Executives' transac..
01/01	Corporate Officers and Executives' transac..
01/01	Corporate Officers and Executives' transac..

More Official Publications

Upcoming event on INNATE PHARMA

03/18/21

FY 2020 Earnings Release

Company calendar

Upcoming sector events

02/01/21	VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Release
02/02/21	BIO-TECHNE CORPORATION : Interim 2021 Earnings Release
02/03/21	QIAGEN N.V. : FY 2020 Earnings Release (Projected)
02/04/21	NEUROCRINE BIOSCIENCES, INC. : FY 2020 Earnings Release

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Biotechnology & Medical Research
			Biotechnology & Medical Research
				Biotechnology & Medical Research - Other